Ewha Med J.  2020 Jan;43(1):1-11. 10.12771/emj.2020.43.1.1.

Intelectin-1 and Endocrinological Parameters in Women with Polycystic Ovary Syndrome: Effect of Insulin Resistance

• Al-Fartosy AJM
• Awad NA
• Mohammed A

• KMID: 2468838
• DOI: http://doi.org/10.12771/emj.2020.43.1.1

Abstract

OBJECTIVES
We aimed to evaluate the effect of insulin resistance (IR) on serum Intelectin-1 and endocrinological hormones levels in obese and non-obese women with and without polycystic ovary syndrome (PCOS) in Basrah, Iraq.
METHODS
From 124 women volunteers, 60 patients with primary and 64 patients with secondary, while 56 normal ovulatory women were taken as controls. Their fasting insulin hormone, intelectin-1, anti-Mullerian hormone, luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), estradiol (E2) and testosterones (T) were determined by ELISA methods. BMI, glucose and quantitative insulin sensitivity check index as well as IR was determined by the homeostasis model assessment.
RESULTS
A significant changes (P<0.05) were seen in the level of homeostasis model assessment-IR, E2 and T. Levels of anti-Mullerian hormone, LH, LH/FSH ratio and prolactin were significantly (P<0.01) increased and level of intelectin-1 and E2/T ratio were significantly (P<0.01) decreased, while quantitative insulin sensitivity check index level was not significantly different (P>0.05) between the patients (1°PCOS and 2°PCOS) and control groups. On the other hand, our data reported that FSH level was significantly (P<0.05) lower in obese and higher in non-obese patients with PCOS as compared to control group.
CONCLUSION
Levels of intelectin-1 and endocrinological hormones have significantly associated with body mass index, IR and physical activity in patients and normal groups and the strategies that can modulate levels of these parameters would improve metabolic disarrangements in women with PCOS.

Keyword

Intelectin-1; Body mass index; Insulin resistance; Gonadal steroid hormones; Polycystic ovary syndrome

MeSH Terms

Anti-Mullerian Hormone
Body Mass Index
Enzyme-Linked Immunosorbent Assay
Estradiol
Fasting
Female
Follicle Stimulating Hormone
Glucose
Gonadal Steroid Hormones
Hand
Homeostasis
Humans
Insulin Resistance*
Insulin*
Iraq
Luteinizing Hormone
Motor Activity
Polycystic Ovary Syndrome*
Prolactin
Volunteers
Anti-Mullerian Hormone
Estradiol
Follicle Stimulating Hormone
Glucose
Gonadal Steroid Hormones
Insulin
Luteinizing Hormone
Prolactin

Reference

1. Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015; 149:R219–R227.

2. Le MT, Le VN, Le DD, Nguyen VQ, Chen C, Cao NT. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2019; 90:579–585.

3. Bannigida DM, Shivananda Nayak B, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Arch Physiol Biochem. 2018; 11. 17. DOI: 10.1080/13813455.2018.1499120. [Epub].

4. Kenawi MZ, Akl EM, Sabry JH, Mostafa ST. Evaluation of serum level of omentin-1 in females with hirsutism. J Cosmet Dermatol. 2019; 06. 13. DOI: 10.1111/jocd.13043. [Epub].

5. Tang YL, Yu J, Zeng ZG, Liu Y, Liu JY, Xu JX. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2017; 33:244–249.

6. Infertility workup for the women's health specialist: ACOG Committee Opinion, number 781. Obstet Gynecol. 2019; 133:e377–e384.

7. Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015; 19:160–164.

8. Ekka DC, Jain A, Puri M. Role of hormones in unexplained infertility. Indian J Med Biochem. 2016; 20:34–37.

9. Callahan TL, Caughey AB. Puberty, the menstrual cycle, and the menopause: infertility and assisted reproductive technologies.In : Callahan TL, Caughey AB, editors. Blueprints obstetrics and gynecology. 7th ed. Philadelphia: Wolters Kluwer Health;2018. p. 212–222.

10. Zhou Y, Zhang B, Hao C, Huang X, Li X, Huang Y, et al. Omentin-A novel adipokine in respiratory diseases. Int J Mol Sci. 2017; 19:E73.

11. Guzel EC, Celik C, Abali R, Kucukyalcin V, Celik E, Guzel M, et al. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecol Endocrinol. 2014; 30:419–422.

12. Guvenc Y, Var A, Goker A, Kuscu NK. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res. 2016; 44:796–805.

13. Kareem JM, Hashim ZH, Almoayed HA. The relation of serum omentin-1 level with insulin resistance in patients with polycystic ovary syndrome and its relation with metformin treatment. Iraqi JMS. 2017; 15:327–338.

14. Barbosa G, Cunha de Sa LB, Rocha DR, Arbex AK. Polycystic ovary syndrome (PCOS) and fertility. Open J Endocr Metab Dis. 2016; 6:58–65.

15. Ambiger S. Study of insulin resistance and lipid profile in polycystic ovarian syndrome. Int J Sci Res Publ. 2016; 6:1–5.

16. Kumar AN, Naidu JN, Satyanarayana U, Anitha M, Ramalingam K. Association of insulin resistance and serum 25-OH vitamin-D in Indian women with polycystic ovary syndrome. Int J Clin Biochem Res. 2015; 2:22–26.

17. Cakir E, Topaloglu O, Colak Bozkurt N, Karbek Bayraktar B, Gungunes A, Sayki Arslan M, et al. Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism. Turk J Med Sci. 2014; 44:781–786.

18. Chaudhari N, Dawalbhakta M, Nampoothiri L. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile. Reprod Biol Endocrinol. 2018; 16:37.

19. Lal L, Bharti A, Perween A. To study the status of LH: FSH ratio in obese and non-obese patients of polycystic ovarian syndrome. IOSR J Dent Med Sci. 2017; 16:20–23.

20. Chen J, Shen S, Tan Y, Xia D, Xia Y, Cao Y, et al. The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome. J Ovarian Res. 2015; 8:11.

21. Shaw ND, Srouji SS, Welt CK, Cox KH, Fox JH, Adams JM, et al. Evidence that increased ovarian aromatase activity and exdkanpression account for higher estradiol levels in African American compared with Caucasian women. J Clin Endocrinol Metab. 2014; 99:1384–1392.

22. Gonzalez B, Ratner LD, Scerbo MJ, Di Giorgio NP, Poutanen M, Huhtaniemi IT, et al. Elevated hypothalamic aromatization at the onset of precocious puberty in transgenic female mice hypersecreting human chorionic gonadotropin: effect of androgens. Mol Cell Endocrinol. 2014; 390:102–111.

23. Indira M, Babu CS. Estrogen, progesterone and serum prolactin levels in infertility cases of women. IOSR J Dent Med Sci. 2015; 14:21–26.

24. Khalaf BH. The effect of long term administration of metformin on prolactin level and C-reactive protein in newly diagnosed level and women with type II diabetes mellitus. World J Pharm Pharm Sci. 2015; 4:156–169.

25. Al-Fartosy AJ, Awad NA, Mahmood RA. A comparison study of leptin, oxidant/antioxidant status and some trace elements in women of healthy control and unexplained infertility in Basrah-Iraq. Indones Biomed J. 2019; 11:327–337.

26. Kanwar G, Jain N, Shekawat M, Sharma N. Estimation of LH, FSH, prolactin and TSH levels in polycystic ovarian syndrome and correlation of LH and FSH with serum TSH levels. IOSR J Dent Med Sci. 2015; 14:64–68.

27. Grachev P, Li XF, Goffin V, O'Byrne KT. Hypothalamic prolactin regulation of luteinizing hormone secretion in the female rat. Endocrinology. 2015; 156:2880–2892.

28. Hasan JS, Ali AH, Baqir M, Fakhrildin MB. Role of prolactin in Iraqi obese women with polycystic ovary syndrome. Am J Med Med Sci. 2015; 5:135–139.

29. Szosland K, Pawlowicz P, Lewinski A. Prolactin secretion in polycystic ovary syndrome (PCOS). Neuro Endocrinol Lett. 2015; 36:53–58.